Cite Filings / ORMP / 0001493152-26-051853

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

ORAMED PHARMACEUTICALS INC. Filed 2026-11-13 Acc 0001493152-26-051853

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-11-13 4 Director acquired 75,670 shares (grant or award)
2026-11-13 4 Director acquired 73,830 shares (grant or award)
2026-11-13 4 Director acquired 74,250 shares (grant or award)
2026-11-13 4 Director acquired 75,670 shares (grant or award)
2026-11-13 4 President and CEO acquired 1,317,000 shares (grant or award)
2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…